Single-cell tumor-immune microenvironment of BRCA1/2 mutated high-grade serous ovarian cancer.
|
IF: 17.694
|
Cited by: 15
|

Abstract

The majority of high-grade serous ovarian cancers (HGSCs) are deficient in homologous recombination (HR) DNA repair, most commonly due to mutations or hypermethylation of the BRCA1/2 genes. We aimed to discover how BRCA1/2 mutations shape the cellular phenotypes and spatial interactions of the tumor microenvironment. Using a highly multiplex immunofluorescence and image analysis we generate spatial proteomic data for 21 markers in 124,623 single cells from 112 tumor cores originating from 31 tumors with BRCA1/2 mutation (BRCA1/2mut), and from 13 tumors without alterations in HR genes. We identify a phenotypically distinct tumor microenvironment in the BRCA1/2mut tumors with evidence of increased immunosurveillance. Importantly, we report a prognostic role of a proliferative tumor-cell subpopulation, which associates with enhanced spatial tumor-immune interactions by CD8+ and CD4 + T-cells in the BRCA1/2mut tumors. The single-cell spatial landscapes indicate distinct patterns of spatial immunosurveillance with the potential to improve immunotherapeutic strategies and patient stratification in HGSC.

Keywords

Spatial Proteomics
mIF

MeSH terms

BRCA1 Protein
BRCA2 Protein
CD4-Positive T-Lymphocytes
CD8-Positive T-Lymphocytes
Carcinoma, Ovarian Epithelial
Cystadenocarcinoma, Serous
Female
Genes, BRCA1
Genes, BRCA2
Genotype
Homologous Recombination
Humans
Mutation
Ovarian Neoplasms
Prognosis
Proteomics
Tumor Microenvironment

Authors

Launonen, I-M
Lyytikäinen, N
Casado, J
Anttila, E A
Szabó, A
Haltia, U-M
Jacobson, C A
Lin, J R
Maliga, Z
Howitt, B E
Strickland, K C
Santagata, S
Elias, K
D'Andrea, A D
Konstantinopoulos, P A
Sorger, P K
Färkkilä, A

Recommend literature



Similar data